Companies Dominating the Nonalcoholic Steatohepatitis Diagnostics Landscape
- Echosen
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Prometheus Laboratories
- Genfit
- Siemens Medical Solutions USA, Inc.
- BioPredictive
- Quest Diagnostics Incorporated.
- Meridian Bioscience, Inc.
- Laboratory Corporation of America Holdings
- Bristol-Myers Squibb Company
- One Way Liver SL
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
2025 Nonalcoholic Steatohepatitis Diagnostics Market is estimated at USD 1.81 billion.
The global nonalcoholic steatohepatitis diagnostics market size was valued at over USD 1.52 billion in 2024 and is predicted to grow at a CAGR of more than 23.6%, surpassing USD 23.88 billion by 2037.
Asia Pacific is expected to hold a leading industry share, fueled by the rising NAFLD and NASH burden in the region.
The major players in the market include Echosen, Prometheus Laboratories, Genfit, Siemens Medical Solutions USA, Inc., BioPredictive, Quest Diagnostics Incorporated., Meridian Bioscience, Inc., Laboratory Corporation of America Holdings, Bristol-Myers Squibb Company, One Way Liver SL.
